8th Edition Drug Patents & Legal Forum

$499.00

SKU: PHP09388 Categories: ,

Description

Report Code: PHP09388. May, 2009. Toronto, ON

ARTICLE I

International Patent Prosecution

Lenni Carreiro, M.Sc., LL.B.
Patent Counsel, Intellectual Property Dept.
Sanofi Pasteur

ARTICLE II

Balancing Justice and Expedition in Patent Litigation: Some Problems with Streamlining Complex Patent Cases

Jonathan Stainsby
Partner
Heenan Blaikie LLP

Andrew McIntyre, LL.B.
Lawyer
Heenan Blaikie LLP

ARTICLE III

What Patents Must be Addressed in PM(NOC) Proceedings? It Depends on When You Ask!

Michael E. Charles
Partner
Bereskin & Parr LLP

ARTICLE IV

Pharmaceutical Patent Trials Within Two Years

Gunars A. Gaikis
Partner
Smart & Biggar/Fetherstonhaugh & Co.

Dr. Junyi Chen, Ph.D.
Associate
Smart & Biggar/Fetherstonhaugh & Co.

ARTICLE V

Expert Witnesses: From Proper Retention to Cross-examination

Neil R. Belmore
Partner
Belmore McIntosh Neidrauer LLP

ARTICLE VI

Canada’s Patented Medicine Prices Review Board – Moving Forward on the Guidelines Review

Barbara Ouellet
Executive Director
Patented Medicine Prices Review Board (PMPRB)

ARTICLE VII

The Changing Patent Landscape in the United States

Clifford M. Davidson, Esq.
Partner
Davidson, Davidson & Kappel LLC (New York)

ARTICLE VIII

Recent Developments in Utility Law

Barbara J. Murchie
Partner
Bennett Jones LLP

Chandimal Nicholas
Bennett Jones LLP

ARTICLE IX

Canada’s Access to Medicines Regime: A Public Policy Fiasco or Promise?

Dr. Jillian Clare Kohler, Ph.D.
Assistant Professor
Leslie Dan Faculty of Pharmacy
University of Toronto
Initiative for Drug Equity and Access

ARTICLE X

SEBs/Subsequent Entry Biologics: Canadian Legal Update

Teresa Reguly
Associate
Torys LLP

ARTICLE XI

Manning the Barricades: New Chapter 17 of the MOPOP – CIPO’s Policies Concerning the Patentability of Biotechnology-Related Inventions

Yoon Kang
Partner
Smart & Bigger

ARTICLE XII

Section 8 Damages – Recent Developments

Jason C. Markwell
Partner
Ogilvy Renault LLP

Dr. Richard Y. Cheung, Ph.D.
Ogilvy Renault LLP

ARTICLE XIII

Supreme Court of Canada PLAVIX Decision: The Aftermath

Andrew Bernstein
Partner
Torys LLP

Nancy P. Pei
Partner
Smart & Bigger/Fetherstonhaugh & Co.

Angela M. Furlanetto
Partner
Dimock Stratton LLP

Dominique T. Hussey
Partner
Bennett Jones LLP

ARTICLE XIV

Hot Topics in Pharma Litigation

David M. Reive
Partner
Dimock Stratton LLP

ARTICLE XV

Patent Prosecution Highway (PPH) Pilot Program Between CIPO and the USPTO

Javier Jorge
Project Manager of PPH Pilot Project
Examiner – Mechanical
Canadian Intellectual Property Office
Industry Canada